Abstract
Attempts have been made to use various forms of cellular vectors to deliver therapeutic genes to diseased tissues like malignant tumours. However, this approach has proved problematic due to the poor uptake of these vectors by the target tissue. We have devised a novel way of using magnetic nanoparticles (MNPs) to enhance the uptake of such ‘therapeutically armed’ cells by tumours. Monocytes naturally migrate from the bloodstream into tumours, so attempts have been made to use them to deliver therapeutic genes to these sites. However, transfected monocytes injected systemically fail to infiltrate tumours in large numbers. Using a new in vitro assay for assessing monocyte extravasation, we show that the ability of transfected human monocytes to migrate across a human endothelial cell layer into a 3D tumour spheroid is markedly increased when cells are pre-loaded with MNPs and a magnetic force is applied close to the spheroid. Furthermore, systemic administration of such ‘magnetic’ monocytes to mice bearing solid tumours led to a marked increase in their extravasation into the tumour in the presence of an external magnet. This new magnetic targeting approach could be used to increase the targeting, and thus the efficacy, of many cell-based gene therapies in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Luo D, Saltzman WM . Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 2000; 18: 893–895.
Emens LA, Jaffee EM . Cancer vaccines: an old idea comes of age. Cancer Biol Ther 2003; 2: S161–S168.
Leek RD, Landers RJ, Harris AL, Lewis CE . Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999; 79: 991–995.
Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 2003; 163: 1233–1243.
Griffiths L, Binley K, Iqball S, Kan O, Maxwell P, Ratcliffe P et al. The macrophage—a novel system to deliver gene therapy to pathological hypoxia. Gene Therapy 2000; 7: 255–262.
Bartoleyns J, Romet-Lemonne JL, Chokri M, Lopez M . Immune therapy with macrophages: present status and critical requirements for implementation. Immunobiology 1996; 195: 550–562.
Andreesen R, Hennemann B, Krause SW . Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives. J Leukoc Biol 1998; 64: 419–426.
Bartholeyns J, Lopez M, Andreesen R . Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results. Anticancer Res 1991; 11: 1201–1204.
Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M et al. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 2002; 196: 204–212.
Freeman AAaM . Magnetism in medicine. J Appl Phys 1960; 51: S404–S405.
Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K et al. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 1996; 56: 4686–4693.
Goodwin SC, Bittner CA, Peterson CL, Wong G . Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci 2001; 60: 177–183.
Arruebo MF-PR, Ibarra R, Santamaría J . Magnetic nanoparticles for drug delivery. Nanotoday 2007; 2: 22–32.
Wang MD, Shin DM, Simons JW, Nie S . Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther 2007; 7: 833–837.
Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453–2458.
von Zur Muhlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink A et al. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007; 193: 102–111.
Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE . Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004; 14: 1851–1858.
Robinson DM, Keating GM . Albumin-bound Paclitaxel: in metastatic breast cancer. Drugs 2006; 66: 941–948.
Yellen BB, Hovorka O, Friedman G . Arranging matter by magnetic nanoparticle assemblers. Proc Natl Acad Sci USA 2005; 102: 8860–8864.
Mayrovitz HN, Tuma RF, Wiedeman MP . Relationship between microvascular blood velocity and pressure distribution. Am J Physiol 1977; 232: H400–H405.
Schenkel AR, Mamdouh Z, Muller WA . Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 2004; 5: 393–400.
Jin H, Su J, Garmy-Susini B, Kleeman J, Varner J . Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 2006; 66: 2146–2152.
Ross JA . The Biology of the Macrophage. Oxford: Oxford University Press, 2002.
Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003; 228: 760–767.
Verdijk P, Scheenen TW, Lesterhuis WJ, Gambarota G, Veltien AA, Walczak P et al. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer 2007; 120: 978–984.
Strom VHK, Gruttner C, Teller J . A novel and rapid method for quantification of magnetic nanoparticle–cell interactions using a desktop susceptometer. Nanotechnology 2004; 15: 457–466.
Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 2004; 55: 654–659.
Murdoch C, Tazzyman S, Webster S, Lewis CE . Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 2007; 178: 7405–7411.
Lim YC, Snapp K, Kansas GS, Camphausen R, Ding H, Luscinskas FW . Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. J Immunol 1998; 161: 2501–2508.
Lawrence MB, Springer TA . Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859–873.
Acknowledgements
This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), UK. JD acknowledges the support of a Royal Society Wolfson Research Merit Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muthana, M., Scott, S., Farrow, N. et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther 15, 902–910 (2008). https://doi.org/10.1038/gt.2008.57
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2008.57
Keywords
This article is cited by
-
Magnetic nanodrug delivery in non-Newtonian blood flows
Microfluidics and Nanofluidics (2022)
-
Core-shell magnetoelectric nanorobot – A remotely controlled probe for targeted cell manipulation
Scientific Reports (2018)
-
Pd Nanoparticles Immobilized on Supported Magnetic GO@PAMPS as an Auspicious Catalyst for Suzuki–Miyaura Coupling Reaction
Catalysis Letters (2017)
-
Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting
Nature Communications (2015)
-
Highly Efficient Labeling of Human Lung Cancer Cells Using Cationic Poly-l-lysine-Assisted Magnetic Iron Oxide Nanoparticles
Nano-Micro Letters (2015)